Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 8, 2026, Teladoc Health, Inc. (TDOC) has a Wall Street consensus price target of $7.58, based on estimates from 42 covering analysts. With the stock currently trading at $6.96, this represents a potential upside of +8.9%. The company has a market capitalization of $1.26B.
Analyst price targets range from a low of $6.00 to a high of $11.00, representing a 66% spread in expectations. The median target of $7.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 14 analysts rating the stock as a Buy or Strong Buy,28 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, TDOC trades at a trailing P/E of -6.1x. Analysts expect EPS to grow +6.6% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonQuick answers to the most common questions about buying TDOC stock.
The consensus price target for TDOC is $7.58, close to the current price of $6.961 (8.9% implied move). Based on 42 analyst estimates, the stock appears fairly valued near current levels.
TDOC has a consensus rating of "Hold" based on 42 Wall Street analysts. The rating breakdown is mixed, with 28 Hold ratings making up the largest segment. The consensus 12-month price target of $7.58 implies 8.9% upside from current levels.
TDOC's current price is $6.961 with a consensus target of $7.58 (8.9% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $11 for TDOC, while the most conservative target is $6. The consensus of $7.58 represents the median expectation. These targets typically reflect 12-month expectations.
TDOC is heavily covered by Wall Street, with 42 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 14 have Buy ratings, 28 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month TDOC stock forecast based on 42 Wall Street analysts shows a consensus price target of $7.58, with estimates ranging from $6 (bear case) to $11 (bull case). The median consensus rating is "Hold".
TDOC appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $7.58 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
TDOC analyst price targets range from $6 to $11, a 66% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $7.58 consensus represents the middle ground.